Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation.
Husser O, Núñez J, Núñez E, Holzamer A, Camboni D, Luchner A, Sanchis J, Bodi V, Riegger GA, Schmid C, Hilker M, Hengstenberg C.
Husser O, et al. Among authors: sanchis j.
JACC Cardiovasc Interv. 2013 May;6(5):487-96. doi: 10.1016/j.jcin.2013.02.006.
JACC Cardiovasc Interv. 2013.
PMID: 23702013
Free article.